Dexamethasone sodium phosphate 0.1%; oph soln; contains benzalkonium chloride. Initial therapy: 1 or 2 drops in conjunctival ... Mycobacterial infection of the eye. Fungal diseases of ocular ...

The FDA has expanded the approval of Dextenza (dexamethasone ophthalmic insert) to include pediatric treatment.

Leveraging Oculis’ proprietary technology, OCS-01 is an OPTIREACH formulation of high concentration dexamethasone eye drop. It is being developed as an eye drop to treat the retina to offer a ...

Tobramycin 0.3%, dexamethasone 0.05% ... to the initial prescription and renewal of the medication order. Perform ophthalmic examination with the aid of magnification, such as slit lamp ...

OCS-01, leveraging Oculis' proprietary OPTIREACH® technology, is a high-concentration dexamethasone eye drop that aims to offer a non-invasive treatment alternative for DME, a condition that ...